ROBOTIC PELVIC SURGERY (ROPES) I: Robotic Extended Resection for Locally Advanced and Recurrent Pelvic Malignancy: An IDEAL 2B Prospective Study to Design a Phase III Randomised Controlled Trial

Not Applicable

• Conditions: ocally advanced pelvic malignancy; Recurrent pelvic malignancy; Locally advanced pelvic malignancy; Cancer - Neuroendocrine tumour (NET); Cancer - Bowel - Back passage (rectum) or large bowel (colon); Cancer - Bladder; Cancer - Sarcoma (also see 'Bone') - soft tissue; Cancer - Cervical (cervix); Cancer - Prostate; Cancer - Womb (Uterine or endometrial cancer)

• Registration Number: ACTRN12622000331730
• Lead Sponsor: Satish Warrier

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-23
• Last Update Posted: 28 February 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Patients with locally advanced or recurrent pelvic malignancy requiring extended resection
2. Patients in expert centres where a robotic approach is offered to selected cases with locally advanced or recurrent pelvic malignancy

Exclusion Criteria

Patients who do not proceed to surgery.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br><br>To determine the current case volume of robotic assisted surgery for locally advanced or recurrent pelvic malignancy in expert centres. This will be assessed by a study specific questionnaire and data will be entered onto redcap at participating sites. [This primary timepoint will be at the time of selection for surgery, i.e. at initial enrolment into the study. ];To determine current patient selection criteria of robotic assisted surgery for locally advanced or recurrent pelvic malignancy in expert centres. <br><br>The surgical team will enter data on redcap based on a patient selection for robotic surgery questionnaire designed specifically for the study. [for the primary end point, it will be assessed at time of selection for surgery<br>]